EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 123 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,464,000 | +80.5% | 35,200 | 0.0% | 0.84% | +53.8% |
| Q2 2016 | $1,365,000 | -4.3% | 35,200 | 0.0% | 0.55% | -7.8% |
| Q1 2016 | $1,426,000 | -54.3% | 35,200 | 0.0% | 0.59% | -32.6% |
| Q4 2015 | $3,121,000 | -64.8% | 35,200 | -70.6% | 0.88% | -48.3% |
| Q3 2015 | $8,876,000 | -22.3% | 119,900 | -15.1% | 1.70% | +57.7% |
| Q2 2015 | $11,426,000 | +68.3% | 141,300 | -12.8% | 1.08% | +68.0% |
| Q1 2015 | $6,790,000 | +119.0% | 162,100 | -19.0% | 0.64% | +115.8% |
| Q4 2014 | $3,100,000 | +22.5% | 200,000 | 0.0% | 0.30% | +13.8% |
| Q3 2014 | $2,530,000 | -11.7% | 200,000 | 0.0% | 0.26% | +6.1% |
| Q2 2014 | $2,866,000 | +12.4% | 200,000 | 0.0% | 0.25% | +18.3% |
| Q1 2014 | $2,550,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |